{
  "title": "18",
  "slices": [
    {
      "filter": {
        "name": "ONCOLOGY_CHPA_ BRAND_1_MAPPING",
        "description": "from display and timeline",
        "factory": "com.pharbers.process.stm.step.pptx.filter.phSearchFilterImpl",
        "filt": []
      },
      "sliders": [
        {
          "title": "Gemzar and Alimta Key Competitors Cash Performance in CHPA (MAT)",
          "content": {
            "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentImpl",
            "texts": [
              {
                "pos": [
                  0, 0, 100, 100
                ],
                "font": "",
                "text": ""
              }
            ],
            "tables": [
              {
                "factory": "com.pharbers.process.stm.step.pptx.slider.content.phReportContentTableImpl",
                "mkt_display": "",
                "mkt_col": "",
                "pos": [
                  30, 60, 81, 81
                ],
                "timeline": [
                  "MAT M09 18:timeline_2", "MAT M09 17:timeline_2"
                ],
                "col": {
                  "title" : ":col_title_common",
                  "count" : [
                    "RMB(Mn):col_common1",
                    "SOM(%):col_common",
                    "Growth(%):col_common"
                  ]
                },
                "row": {
                  "title" : ":row_title_common",
                  "display_name" : [
                    "Oncology Mkt:row_1"
                  ]
                }
              }


            ]
          }
        }
      ]
    }
  ]
}